Figure 7From: Repression of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) but not its receptors during oral cancer progressionDcR1 and DcR2 immunohistochemical staining of the lesion shown in figure 5 (× 100). Immunoreactivity for DcR1 (top) is not altered in dysplasia compared to adjacent uninvolved mucosa. Focal loss of DcR2 expression (bottom) is noted in dysplasia compared to adjacent uninvolved mucosa.Back to article page